Adverse Effects

Brain Cancer

HER2-Positive Breast Cancer

Triple-Negative Breast Cancer

Breast Cancer

Colorectal Cancer

Esophageal Cancer

Gastric Cancer

Liver Cancer

Pancreatic Cancer

Gastrointestinal Cancer

Bladder Cancer

Kidney Cancer

Prostate Cancer

Genitourinary Cancers

Cervical Cancer

Endometrial Cancer

Ovarian Cancer

Gynecologic Cancers

Head & Neck Cancer

Multiple Myeloma

Myelodysplastic Syndromes

Myeloproliferative Neoplasms

Hematologic Oncology

Vaccines

Infection

Leukemia

Non-Small Cell Lung Cancer (NSCLC)

Small Cell Lung Cancer (SCLC)

Lung Cancer

Lymphoma

Neuroendocrine Tumors

Oncology

Pediatric Cancers

Radiation Oncology

Sarcoma

Screening

Skin Cancer & Melanoma

Surgery

Thyroid Cancer

News

Global Bulletin

All News

FDA Approval Alert

Women in Oncology

Media

Expert Interviews

Around the Practice

Between the Lines

Face Off

From All Angles

Meeting of the Minds

OncView

Podcasts

Training Academy

Treatment Algorithms with the Oncology Brothers

Conferences

Publications

All Journals

Editorial Board

For Authors

Year in Review

Events

Frontline Forum

Satellite Sessions

CME/CE

Resources

Awareness Month

Interactive Tools

Nurse Practitioners/Physician's Assistants

Partners

Career Center

Subscribe

CancerNetwork is home to the journal Oncology & provides insights on the screening, early detection, diagnosis, treatment and prevention of cancers.

About

Advertise

CureToday.com

OncLive.com

OncNursingNews.com

TargetedOnc.com

Editorial

Contact

Terms and Conditions

Privacy

Do Not Sell My Personal Information

CancerNetwork - Oncology News and Clinical Expertise

Facebook

LinkedIn

Spotlight

Clinical

Genitourinary Cancer

Gynecologic Cancer

Hematology

Skin Cancer

1rem

View

Transforming Transplant-Ineligible Newly Diagnosed Multiple Myeloma: From Real-World Evidence to Clinical Practice

Videos

Joselle Cook, M.B.B.S and Matthew James Pianko, MD review the latest updates concerning transplant-ineligible newly diagnosed multiple myeloma (NDMM) and provide insights on the real-world application of clinical data to improve patient outcomes.

Joselle Cook, M.B.B.S and Matthew James Pianko, MD discuss available treatment options and goals of therapy for patients with transplant-ineligible NDMM. 

Goals of Therapy and Treatment Options for Patients with Transplant-Ineligible NDMM 

A summary of updates from the MAIA and SWOG S0777 studies, with a focus on efficacy and tolerability data.

Clinical Implications from the MAIA and SWOG S0777 Studies 

Conversation centered around patient frailty, Dr. Cook and Dr. Pianko emphasize the importance of accurately assessing frailty and adjusting treatment plans accordingly.

Assessing and Supporting Frail Patients with NDMM

Clinical pearls for community oncologists concerning the real-world application of existing treatments while considering feasibility, cost, and ease of care.

Implementing Real-world Evidence into Clinical Practice in NDMM

Dr. Cook and Dr. Pianko share their perspectives on optimizing treatment strategies for individual patients in order to maximize response and mitigate adverse events.

Optimizing Treatment Duration and Adverse Effect Management in Patients with NDMM 

Closing thoughts on unmet needs in the multiple myeloma space, particularly disparities in the care of patients with MM of racial and ethnic minorities.

Addressing Unmet Needs and Disparities Across Patient Populations in Multiple Myeloma 

Experts discuss key data updates in real-world newly diagnosed multiple myeloma practices, and how these findings may change the treatment paradigm.

Frontline Forum: Real-World Practice in Newly Diagnosed Multiple Myeloma

Implementing Real-world Evidence into Clinical Practice in NDMM

EP: 1.Goals of Therapy and Treatment Options for Patients with Transplant-Ineligible NDMM

EP: 2.Clinical Implications from the MAIA and SWOG S0777 Studies

EP: 3.Assessing and Supporting Frail Patients with NDMM

EP: 4.Implementing Real-world Evidence into Clinical Practice in NDMM

EP: 5.Optimizing Treatment Duration and Adverse Effect Management in Patients with NDMM

EP: 6.Addressing Unmet Needs and Disparities Across Patient Populations in Multiple Myeloma

EP: 7.Frontline Forum: Real-World Practice in Newly Diagnosed Multiple Myeloma